InvestorsHub Logo
Followers 0
Posts 87
Boards Moderated 0
Alias Born 03/10/2013

Re: Nukemtiltheyglow post# 161026

Monday, 11/19/2018 1:43:07 PM

Monday, November 19, 2018 1:43:07 PM

Post# of 427376
Here's a cheat sheet someone more knowlegeable than me posted a week or two ago. The most debatable point to me would be the PE. Don't forget about supply limitations. CEO only coralled enough to support $1B revenue before results were known.

rounded numbers, ~$25 share price per 1M patients per year

revenue per capsule: $1.00
capsules/day: 4
revenue per patient per year: $1,500
patients per year: 1M
annual revenues: 1.5B
net profit margin: 30%
EBITDA: $450M
fully diluted shares outstanding: 373M
earnings/share: $1.20
P/E multiplier: 20
share price: $24
market capitalization: $9B

kilograms of API per year: 1,500,000
metric tonnes of API per year: 1,500
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News